WVE. They are about to release data on their Huntington disease program. The stock cratered -60% a few days ago after they announced discontinuation for DMD program in earlier phase. The company is working on the space of ASOs. Currently is at 52wl. I like to search for "falling angels" but this one seems to risky. Anyone has any insight? comments on it?
Market Data 
Markets 
AI
